An observational study in Hypertensive Emergency, Papilledema and Hypertension, sponsored by Leiden University Medical Center. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-09.
Sponsored by Leiden University Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This prospective observational study investigates the potential of point-of-care ultrasonography of the optic nerve sheath diameter (ONSD) to rule out papilledema in patients with suspected hypertensive emergency. The primary focus is on assessing ONSD sensitivity in identifying papilledema (hypertensive retinopathy grade 4), while secondary endpoints include hypertensive retinopathy grade 3, hypertensive encephalopathy, and the need for intravenous rapid-acting medications to lower elevated blood pressure. This study aims to determine the diagnostic characteristics of this procedure for the diagnosis of hypertensive retinopathy, thus assessing its potential as a screening tool to rule out hypertensive retinopathy by the acute internal medicine doctor.
31 studies on the registry are indexed under Hypertensive Crisis; 9 are open to participants now.
This study's planned enrollment of 375 is close to the median of 361 across 10 observational studies indexed under Hypertensive Crisis.
Browse Hypertensive Crisis studies →Leiden University Medical Center is the lead sponsor of 334 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients presenting to the emergency department with suspected hypertensive emergency.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Point of care ultrasonography of the optic nerve sheath diameter
Papilledema
Sensitivity of ONSD \> 5mm for diagnosis of papilledema
Time frame: 2 years
Hypertensive retinopathy grade 3 & 4 combined
Sensitivity/specificity of the ONSD for hypertensive retinopathy grade 3 \& 4 combined
Time frame: 2 years
Hypertensive encephalopathy
Sensitivity/specificity of the ONSD for hypertensive encephalopathy
Time frame: 2 years
Rapid acting medications administered intravenously to lower the elevated blood pressure
Sensitivity/specificity of the ONSD for the need for rapid acting medications administered intravenously to lower the elevated blood pressure
Time frame: 2 years
Presence of a bulging optic nerve disc and/or crescent sign found by ultrasonography of the optic nerve
Diagnostic characteristics for the presence of a bulging optic nerve disc and/or crescent sign for above mentioned diagnoses (papilledema, hypertensive retinopathy grade 3\&4 combined, hypertensive encephalopathy, need for rapid acting intravenous medications to lower elevated bloodpressure).
Time frame: 2 years
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Nov 2024; primary completion for Nov 2026, 24 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Leiden University Medical Center →